CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

TENIVAC

RegulatoryapprovedTENIVACPositive
AI Analysis

Summary

TENIVAC has received product approval for active immunization against tetanus and diphtheria in persons 7 years of age and older.

Outcome Details

Product approval for TENIVAC

Importance:6/10
Sentiment:
0.70
FDA approvalvaccineimmunizationtetanusdiphtheria

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 27, 2026 3:40 PM

Read Original